News from the MCRC
Director's Update
04/03/2022
MCRC Director’s Update – February 2022
TARGET National, Stampede, and DETERMINE clinical trials, as well as activities from World Cancer Day and Equality Diversity and Inclusivity cap off February at the MCRC.
Researcher Stories
02/03/2022
Thomas Kedward
We speak to Thomas Kedward about his PhD and the use of proteogenomics to connect somatic mutations to signalling in 
breast cancer patient-derived organoids.
Director's Update
04/02/2022
Introducing On Cancer
Professor Rob Bristow outlines the importance of the On Cancer publication and engagement of policy makers alongside our unique research and technologies here in Manchester.
Researcher Stories
17/01/2022
Hadiyat Ogunlayi
Research Spotlight
05/01/2022
Cancer researchers across the UK join forces to find drugs for rare cancers
DETERMINE is the first UK national precision medicine trial in rare cancers, testing a range of therapies specifically targeting key genetic changes in cancer cells.
MCRC Blog
17/12/2021
Cancer Revolution: Science, Innovation and Hope
Director's Update
16/12/2021
MCRC Director’s Update – December 2021
At the end of 2021, we look back and reflect on the some of our major accomplishments and challenges of the past year, and a look ahead to 2022.
Director's Update
29/11/2021
MCRC Director’s Update – November 2021
Researcher Stories
23/11/2021
Madeleine Strach
We speak to Madeleine Strach about rare cancers and her work with The Christie Colorectal and Peritoneal Oncology Centre (CPOC) research group on appendix cancer.
MCRC Blog
19/11/2021
ACES (Alternative Cervical Screening): Acceptability of a urine self-test for cervical screening in the LGBTQ+ population
Researcher Stories
12/11/2021
Jim Zhong – CRUK Leeds-Manchester Clinical Research Training Fellow
We speak to Jim Zhong about his CRUK Leeds-Manchester Clinical Research Training Fellow.
MCRC Blog
11/11/2021
CRUK Manchester Centre PhD Training Schemes
MCRC Blog
08/11/2021
Re-write Cancer: Manchester Can…
In the next five years, Manchester can: "Use your blood sample to understand unique molecular features of your cancer in real-time."
Director's Update
08/11/2021
Paterson Building Development Update – November 2021
As the building reaches its highest point of construction, Professor Nic Jones, Director of Strategic Initiatives at the MCRC updates in the second of our new quarterly updates.
